News & Insight

2 November 2021
Video
Why virtual reality is the future
A short film from Columbia Cancer Research featuring members of our IMAXT team – co-investigators Simon Tavaré and Owen Harris, and postdoctoral researcher Ignacio Vazquez-Garcia. Learn more about the IMAXT team.

Latest

News
25 October 2021
The Cancer Grand Challenges Mutographs team has added an unexpected piece to the complex puzzle surrounding the development of oesophageal squamous…
News
24 October 2021
Oesophageal squamous cell carcinoma (ESCC) is the most common type of oesophageal cancer – a disease that affected more than 600,000 people worldwide…
News
20 October 2021
Surprising discoveries from the Mutographs team challenge the classical view that all carcinogens directly cause mutations and suggest that non-…
News
20 October 2021
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science.  Discover …

Latest tweet

Congrats to Barry Stein, patient advocate of our OPTIMISTICC team on receiving the 2021 @CCRAlliance award for Exce… https://t.co/2QT77jZKlr Fri Dec 17 15:05:14 +0000 2021

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
Video
Sir Mike Stratton, based at the Wellcome Sanger Institute in Cambridge, UK, leads the Cancer Grand Challenges Mutographs team. Mutographs unites genomicists with epidemiologists, building on recent developments in…
22 July 2021
News
Earlier this year, COSMIC - the world's largest and most comprehensive resource for exploring somatic mutations in cancer - celebrated the curation of its 10 millionth mutation.  PhD student Ellie Dunstone discusses…
13 July 2021
Video
Johanna Joyce is co-investigator of the Cancer Grand Challenges IMAXT team, based in Lausanne, Switzerland.   We caught up with Johanna to learn how diverse, global collaboration is helping to unlock new information…
30 June 2021
Video
Nearly 170 diverse, global teams submitted bold ideas outlining how they would solve some of cancer’s toughest challenges. Today, we reveal the 11 teams selected to compete for a share of £80m.   We were delighted to…
21 June 2021
News
APC is one of the most commonly mutated genes in colorectal tumours – but why is it so frequently mutated in this type of cancer compared to others? The answer lies in the way APC-mutant cells compete with their…
3 June 2021
Video
Patient advocate Helen Matthews meets co-investigator Owen Sansom to discuss SPECIFICANCER’s latest findings, how working cross-discipline enables ‘big strides forward’ and the unique, important perspectives brought to…
1 June 2021
News
New findings from the OPTIMISTICC team reveal aspirin’s antibacterial activity against Fusobacterium nucleatum, an oncomicrobe known to drive colorectal cancer.   OPTIMISTICC’s Caitlin Brennan, postdoctoral fellow and…
21 April 2021
News
By distinguishing between people with ductal carcinoma in situ (DCIS) who will develop invasive breast cancer and those who won’t, the Cancer Grand Challenges PRECISION team could spare thousands of women around the…
15 April 2021
Video
Look inside the IMAXT team’s virtual reality lab, ahead of its release later this year, as the team calls for volunteers to help test the software.   A core component of the Cancer Grand Challenges IMAXT programme,…
13 April 2021